Taipei, Aug. 19 (CNA) The National Health Insurance Administration (NHIA) will evaluate including a one-time gene therapy to treat individuals with hemophilia B in the NHI drug reimbursement scheme after it is approved in Taiwan, an NHIA official sai
![NHIA to assess paying hefty price for new hemophilia B gene therapy](https://img.easybranches.com/uploads/news/2024/08/nhia-to-assess-paying-hefty-price-for-new-hemophilia-b-gene-therapy.jpg)